# UGDH

## Overview
The UGDH gene encodes the enzyme UDP-glucose 6-dehydrogenase, which is a critical component in the biosynthesis of UDP-glucuronic acid from UDP-glucose. This enzyme is categorized as an oxidoreductase and plays a pivotal role in the formation of glycosaminoglycans, such as hyaluronan, chondroitin sulfate, and heparan sulfate, which are essential for the structural integrity and function of the extracellular matrix (Sommer2004Characterization; Egger2011Structure). The UGDH enzyme functions as a hexamer and is regulated by substrate availability and feedback inhibition, particularly by UDP-xylose (Egger2011Structure; Zimmer2020Integration). Dysregulation of UGDH can lead to significant impacts on cellular processes, including detoxification, embryogenesis, and cellular growth, and has been implicated in various developmental disorders and cancer progression (Kadirvelraj2011Role; Teoh2020UDPglucose; Hengel2020Lossoffunction).

## Structure
The human UDP-glucose 6-dehydrogenase (UGDH) enzyme is a hexamer composed of six subunits, each with a molecular weight of approximately 57 kDa. The enzyme's structure is organized into three domains: an NAD+ binding domain, a dimerization domain, and a nucleotide sugar binding domain (Sennett2011Conformational). The primary structure of UGDH consists of a sequence of amino acids that form the polypeptide chain, with specific residues such as Cys 276 and Asp 280 playing crucial roles in the active site and catalysis (Rajakannan2011Structural).

The secondary structure of UGDH includes α-helices and β-sheets, with the N-terminal domain featuring a Rossmann fold, which is typical for nucleotide-binding proteins (Egger2010UDPglucose). The tertiary structure of each subunit is characterized by two α/β domains, each with a six-stranded parallel β-sheet core flanked by α-helices (Egger2011Structure). The quaternary structure of UGDH is a hexamer, formed by a trimer of dimers, with each dimer pair related by a three-fold symmetry axis (Egger2010UDPglucose).

The enzyme's hexameric structure is stabilized by intersubunit contacts, including hydrophobic interactions and hydrogen bonds, and is sensitive to feedback inhibition by UDP-Xylose, which induces conformational changes (Kadirvelraj2014Hysteresis).

## Function
UDP-glucose 6-dehydrogenase (UGDH) is an enzyme that plays a critical role in the biosynthesis of UDP-glucuronic acid from UDP-glucose, a key precursor in the formation of glycosaminoglycans such as hyaluronan, chondroitin sulfate, and heparan sulfate. These glycosaminoglycans are essential components of the extracellular matrix, contributing to cellular structural integrity, signaling, and tissue repair (Sommer2004Characterization; Egger2011Structure; Rajakannan2011Structural).

In healthy human cells, UGDH is involved in the detoxification process through glucuronidation, where UDP-glucuronic acid is conjugated to various substances, facilitating their excretion. This process is crucial for the metabolism of drugs and other xenobiotics in the liver (Kadirvelraj2011Role; Rajakannan2011Structural). UGDH is active in the cytoplasm and functions as a hexamer, with its activity regulated by substrate availability and feedback inhibition by UDP-xylose (Egger2011Structure; Zimmer2020Integration).

The enzyme's activity is vital for maintaining cellular homeostasis and supporting processes such as embryogenesis and normal cellular growth. Dysregulation of UGDH can impact cellular processes, including epithelial-mesenchymal transition and extracellular matrix remodeling, which are important for cell migration and invasion (Sommer2004Characterization; Zimmer2020Integration).

## Clinical Significance
Mutations in the UGDH gene are associated with several developmental and neurological disorders. Loss-of-function mutations in UGDH have been linked to Jamuar Syndrome, a novel Mendelian disease characterized as a type of early infantile epileptic encephalopathy (EIEE). These mutations result in developmental epileptic encephalopathy with varying degrees of developmental delay, due to impaired neuronal development and underdeveloped cerebral organoids derived from patient cells (Hengel2020Lossoffunction). The UGDH enzyme is crucial for producing UDP-glucuronic acid (UDP-GlcA), a key component in glycosaminoglycans (GAGs) synthesis, which are essential for neuronal development and plasticity (Hengel2020Lossoffunction).

A specific missense mutation, c.950 G>A (p.Arg317Gln), has been identified in exon 8 of the UGDH gene. This mutation is associated with global developmental delay, axial hypotonia, and subtle dysmorphic features. It disrupts the UGDH core structure, affecting residue interactions and destabilizing the enzyme's dimer-hexamer equilibrium, leading to decreased enzyme activity and hyaluronate production (Alhamoudi2020A). This variant has been observed in a consanguineous Saudi family, suggesting it may be a founder mutation in this population (Alaamery2024Case).

Alterations in UGDH expression levels have also been implicated in cancer progression. High expression of UGDH is associated with worse survival outcomes in breast cancer patients, as it plays a role in cell migration and metastasis (Teoh2020UDPglucose).

## Interactions
UDP-glucose 6-dehydrogenase (UGDH) participates in various interactions that are crucial for its function and regulation. UGDH forms a hexameric structure, which is stabilized by non-covalent interactions between its subunits. These interactions are essential for its enzymatic activity and are influenced by the presence of substrates and cofactors, such as UDP-glucose and NAD+ (Egger2011Structure; Zimmer2020Integration). 

The enzyme's activity is also modulated by its interaction with UDP-xylose, a competitive inhibitor that binds to the UDP-glucose binding site, causing a conformational change that stabilizes an inactive state of the enzyme (Zimmer2020Integration). This interaction highlights the enzyme's allosteric regulation, which is influenced by structural rearrangements at the dimer-dimer interface and the intrinsically disordered C-terminal tail (Zimmer2020Integration).

Mutations affecting the dimer-dimer interactions can lead to altered enzyme stability and function, impacting its role in cellular processes such as proteoglycan synthesis and cellular invasion (Zimmer2020Integration). These interactions and structural dynamics are critical for UGDH's role in metabolic pathways and its potential involvement in disease states.


## References


[1. (Egger2011Structure) Sigrid Egger, Apirat Chaikuad, Kathryn L. Kavanagh, Udo Oppermann, and Bernd Nidetzky. Structure and mechanism of human udp-glucose 6-dehydrogenase. Journal of Biological Chemistry, 286(27):23877–23887, July 2011. URL: http://dx.doi.org/10.1074/jbc.m111.234682, doi:10.1074/jbc.m111.234682. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.234682)

[2. (Rajakannan2011Structural) Venkatachalam Rajakannan, Hui-Sun Lee, Seon-Ha Chong, Han-Bong Ryu, Ji-Young Bae, Eun-Young Whang, Jae-Wan Huh, Sung-Woo Cho, Lin-Woo Kang, Han Choe, and Robert C. Robinson. Structural basis of cooperativity in human udp-glucose dehydrogenase. PLoS ONE, 6(10):e25226, October 2011. URL: http://dx.doi.org/10.1371/journal.pone.0025226, doi:10.1371/journal.pone.0025226. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0025226)

[3. (Egger2010UDPglucose) Sigrid Egger, Apirat Chaikuad, Kathryn L. Kavanagh, Udo Oppermann, and Bernd Nidetzky. Udp-glucose dehydrogenase: structure and function of a potential drug target. Biochemical Society Transactions, 38(5):1378–1385, September 2010. URL: http://dx.doi.org/10.1042/bst0381378, doi:10.1042/bst0381378. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bst0381378)

[4. (Hengel2020Lossoffunction) Holger Hengel, Célia Bosso-Lefèvre, George Grady, Emmanuelle Szenker-Ravi, Hankun Li, Sarah Pierce, Élise Lebigot, Thong-Teck Tan, Michelle Y. Eio, Gunaseelan Narayanan, Kagistia Hana Utami, Monica Yau, Nader Handal, Werner Deigendesch, Reinhard Keimer, Hiyam M. Marzouqa, Meral Gunay-Aygun, Michael J. Muriello, Helene Verhelst, Sarah Weckhuysen, Sonal Mahida, Sakkubai Naidu, Terrence G. Thomas, Jiin Ying Lim, Ee Shien Tan, Damien Haye, Michèl A. A. P. Willemsen, Renske Oegema, Wendy G. Mitchell, Tyler Mark Pierson, Marisa V. Andrews, Marcia C. Willing, Lance H. Rodan, Tahsin Stefan Barakat, Marjon van Slegtenhorst, Ralitza H. Gavrilova, Diego Martinelli, Tal Gilboa, Abdullah M. Tamim, Mais O. Hashem, Moeenaldeen D. AlSayed, Maha M. Abdulrahim, Mohammed Al-Owain, Ali Awaji, Adel A. H. Mahmoud, Eissa A. Faqeih, Ali Al Asmari, Sulwan M. Algain, Lamyaa A. Jad, Hesham M. Aldhalaan, Ingo Helbig, David A. Koolen, Angelika Riess, Ingeborg Kraegeloh-Mann, Peter Bauer, Suleyman Gulsuner, Hannah Stamberger, Alvin Yu Jin Ng, Sha Tang, Sumanty Tohari, Boris Keren, Laura E. Schultz-Rogers, Eric W. Klee, Sabina Barresi, Marco Tartaglia, Hagar Mor-Shaked, Sateesh Maddirevula, Amber Begtrup, Aida Telegrafi, Rolph Pfundt, Rebecca Schüle, Brian Ciruna, Carine Bonnard, Mahmoud A. Pouladi, James C. Stewart, Adam Claridge-Chang, Dirk J. Lefeber, Fowzan S. Alkuraya, Ajay S. Mathuru, Byrappa Venkatesh, Joseph J. Barycki, Melanie A. Simpson, Saumya S. Jamuar, Ludger Schöls, and Bruno Reversade. Loss-of-function mutations in udp-glucose 6-dehydrogenase cause recessive developmental epileptic encephalopathy. Nature Communications, January 2020. URL: http://dx.doi.org/10.1038/s41467-020-14360-7, doi:10.1038/s41467-020-14360-7. This article has 37 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-14360-7)

[5. (Sommer2004Characterization) Brandi J. Sommer, Joseph J. Barycki, and Melanie A. Simpson. Characterization of human udp-glucose dehydrogenase. Journal of Biological Chemistry, 279(22):23590–23596, May 2004. URL: http://dx.doi.org/10.1074/jbc.m401928200, doi:10.1074/jbc.m401928200. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m401928200)

[6. (Alhamoudi2020A) Kheloud M. Alhamoudi, Javaid Bhat, Marwan Nashabat, Masheal Alharbi, Yusra Alyafee, Abdulaziz Asiri, Muhammad Umair, and Majid Alfadhel. A missense mutation in the ugdh gene is associated with developmental delay and axial hypotonia. Frontiers in Pediatrics, February 2020. URL: http://dx.doi.org/10.3389/fped.2020.00071, doi:10.3389/fped.2020.00071. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2020.00071)

[7. (Kadirvelraj2014Hysteresis) Renuka Kadirvelraj, Gregory S. Custer, Nicholas D. Keul, Nicholas C. Sennett, Andrew M. Sidlo, Richard M. Walsh, and Zachary A. Wood. Hysteresis in human udp-glucose dehydrogenase is due to a restrained hexameric structure that favors feedback inhibition. Biochemistry, 53(51):8043–8051, December 2014. URL: http://dx.doi.org/10.1021/bi500594x, doi:10.1021/bi500594x. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi500594x)

[8. (Sennett2011Conformational) Nicholas C. Sennett, Renuka Kadirvelraj, and Zachary A. Wood. Conformational flexibility in the allosteric regulation of human udp-α-<scp>d</scp>-glucose 6-dehydrogenase. Biochemistry, 50(44):9651–9663, October 2011. URL: http://dx.doi.org/10.1021/bi201381e, doi:10.1021/bi201381e. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi201381e)

[9. (Zimmer2020Integration) Brenna M. Zimmer, Joseph J. Barycki, and Melanie A. Simpson. Integration of sugar metabolism and proteoglycan synthesis by udp-glucose dehydrogenase. Journal of Histochemistry &amp; Cytochemistry, 69(1):13–23, August 2020. URL: http://dx.doi.org/10.1369/0022155420947500, doi:10.1369/0022155420947500. This article has 28 citations.](https://doi.org/10.1369/0022155420947500)

[10. (Kadirvelraj2011Role) Renuka Kadirvelraj, Nicholas C. Sennett, Samuel J. Polizzi, Stephen Weitzel, and Zachary A. Wood. Role of packing defects in the evolution of allostery and induced fit in human udp-glucose dehydrogenase. Biochemistry, 50(25):5780–5789, June 2011. URL: http://dx.doi.org/10.1021/bi2005637, doi:10.1021/bi2005637. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi2005637)

[11. (Teoh2020UDPglucose) Shao Thing Teoh, Martin P. Ogrodzinski, and Sophia Y. Lunt. Udp-glucose 6-dehydrogenase knockout impairs migration and decreases in vivo metastatic ability of breast cancer cells. Cancer Letters, 492:21–30, November 2020. URL: http://dx.doi.org/10.1016/j.canlet.2020.07.031, doi:10.1016/j.canlet.2020.07.031. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2020.07.031)

[12. (Alaamery2024Case) Manal Alaamery, Salam Massadeh, Manar Aldarwish, Nour Albesher, Nora Aljawini, Othman Alahmed, Amna Kashgari, Christopher A. Walsh, and Wafaa Eyaid. Case report: a founder ugdh variant associated with developmental epileptic encephalopathy in saudi arabia. Frontiers in Genetics, January 2024. URL: http://dx.doi.org/10.3389/fgene.2023.1294214, doi:10.3389/fgene.2023.1294214. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1294214)